Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New approach to tackle haemophilia

20.01.2016

Fighting haemophilia A, a bleeding disorder, with the body's own cells: That is the goal of a new international research consortium led by scientists from Würzburg. The EU funds the project with around €5.5 million.

People suffering from haemophilia A have a genetic deficiency in clotting factor VIII which causes increased bleeding. In extreme cases, unstoppable bleeding may occur that can be life-threatening, in particular if the head or brain region is affected. Joint bleeds occur frequently that can cause permanent damage and even destruction of joints when left untreated.

Although effective treatment of the symptoms is available, there is no cure at present. Patients have to get lifelong infusions several times a week to compensate for the missing clotting factor. The costs of treatment for adults vary between €200,000 and 800,000 per year (source: http://www.g-ba.de).

Genetically modified cells produce the clotting factor

An international research consortium is therefore seeking to develop a novel curative therapy for the disease. Their idea: The patients' own cells are genetically modified outside the body to produce the missing clotting factor using precursor cells of endothelial cells flowing in the bloodstream. Subsequently, these cells are transplanted back into the patient's body in a kind of "cell pouch".

Made of plastic, the pouches measure about 6 x 8 centimetres. They are implanted under the abdominal wall and after they have grown into the tissue, the genetically modified cells are filled into the pouches through a kind of valve. Because the pouches are linked to the blood circulation, the cells are capable of continuously producing the clotting factor and releasing it into the bloodstream for a long period of time. This should mitigate the disease's impact noticeably, increase the patients' quality of life and reduce the cost of therapy.

The research consortium

Under the name HemAcure, the new research consortium unites companies and scientific institutions from Germany, Italy, the UK and Canada. The project will be funded with around €5.5 million under the European Union's Horizon 2020 programme for the next three years. It is headed by Dr. Joris Braspenning, a member of the Department of Tissue Engineering and Regenerative Medicine at the University Hospital Würzburg.

"HemAcure brings together experts from science and industry in a powerful coalition," Joris Braspenning explains. Their knowledge and skills will allow cell-based medical products that comply with European regulations to be developed more quickly and efficiently. He believes that the project will not only benefit patients suffering from severe forms of haemophilia A, but also promote advanced therapies of the future.

Heike Walles, Head of the Department of Tissue Engineering and Regenerative Medicine, is also convinced of the research project's value as, in her words, "it ideally complements the department's value chain and the Translational Center for Regenerative Therapies in Würzburg.

The parties involved

Besides the Department of Tissue Engineering and Regenerative Medicine of the Würzburg University Hospital, the following institutions are involved in HemAcure: GABO:mi, a Munich-based enterprise that specialises in the management of EU-funded collaborative research projects, will be in charge of project management. The quality management will be monitored by IMS - Integrierte Management Systeme in Heppenheim, Germany. The company acts as a point of contact for international projects in the pharmaceutical and medical engineering sector.

The Würzburg University Hospital will be responsible for isolating the cells. Moreover, the entire process will be set up in line with GMP (Good Manufacturing Practice) guidelines for the production of pharmaceutical products.

The Università del Piemonte Orientale (Italy) will perform the gene correction of the patient cells. Scientists from Loughborough University (UK) will focus on the manufacturing process and safety testing. Sernova, a Canadian company, will supply the "cell pouches" for implanting the therapeutic cells.

The Horizon 2020 programme

Horizon 2020 is the biggest EU research and innovation programme ever with nearly €80 billion of funding available over seven years (2014 to 2020). It promises more breakthroughs, discoveries and world firsts by taking great ideas from the lab to the market, for example in the field of personalised medicine providing novel therapies such as gene or cell therapy.

Contact

Dr. Joris Braspenning, Project Manager HemAcure & Business Development Manager
Phone: +49 931 31-88598, joris.braspenning@uni-wuerzburg.de

Gunnar Bartsch | idw - Informationsdienst Wissenschaft
Further information:
http://www.uni-wuerzburg.de

More articles from Awards Funding:

nachricht LandKlif: Changing Ecosystems
06.07.2018 | Julius-Maximilians-Universität Würzburg

nachricht “Future of Composites in Transportation 2018”, JEC Innovation Award for hybrid roof bow
29.06.2018 | Fraunhofer-Institut für Lasertechnik ILT

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Future electronic components to be printed like newspapers

A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.

The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

A smart safe rechargeable zinc ion battery based on sol-gel transition electrolytes

20.07.2018 | Power and Electrical Engineering

Reversing cause and effect is no trouble for quantum computers

20.07.2018 | Information Technology

Princeton-UPenn research team finds physics treasure hidden in a wallpaper pattern

20.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>